183 related articles for article (PubMed ID: 37090716)
1. Rapid and sustained T cell-based immunotherapy against invasive fungal disease via a combined two step procedure.
Tischer-Zimmermann S; Salzer E; Bitencourt T; Frank N; Hoffmann-Freimüller C; Stemberger J; Maecker-Kolhoff B; Blasczyk R; Witt V; Fritsch G; Paster W; Lion T; Eiz-Vesper B; Geyeregger R
Front Immunol; 2023; 14():988947. PubMed ID: 37090716
[TBL] [Abstract][Full Text] [Related]
2. Clinical-scale isolation of the total Aspergillus fumigatus-reactive T-helper cell repertoire for adoptive transfer.
Bacher P; Jochheim-Richter A; Mockel-Tenbrink N; Kniemeyer O; Wingenfeld E; Alex R; Ortigao A; Karpova D; Lehrnbecher T; Ullmann AJ; Hamprecht A; Cornely O; Brakhage AA; Assenmacher M; Bonig H; Scheffold A
Cytotherapy; 2015 Oct; 17(10):1396-405. PubMed ID: 26188965
[TBL] [Abstract][Full Text] [Related]
3. Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies.
Hebart H; Bollinger C; Fisch P; Sarfati J; Meisner C; Baur M; Loeffler J; Monod M; Latgé JP; Einsele H
Blood; 2002 Dec; 100(13):4521-8. PubMed ID: 12393638
[TBL] [Abstract][Full Text] [Related]
4. Clinical-scale generation of human anti-Aspergillus T cells for adoptive immunotherapy.
Tramsen L; Koehl U; Tonn T; Latgé JP; Schuster FR; Borkhardt A; Uharek L; Quaritsch R; Beck O; Seifried E; Klingebiel T; Lehrnbecher T
Bone Marrow Transplant; 2009 Jan; 43(1):13-9. PubMed ID: 18762764
[TBL] [Abstract][Full Text] [Related]
5. Adoptive immunity mediated by HLA-A*0201 restricted Asp f16 peptides-specific CD8+ T cells against Aspergillus fumigatus infection.
Sun Z; Zhu P; Li L; Wan Z; Zhao Z; Li R
Eur J Clin Microbiol Infect Dis; 2012 Nov; 31(11):3089-96. PubMed ID: 22696051
[TBL] [Abstract][Full Text] [Related]
6. Generation of highly purified and functionally active human TH1 cells against Aspergillus fumigatus.
Beck O; Topp MS; Koehl U; Roilides E; Simitsopoulou M; Hanisch M; Sarfati J; Latgé JP; Klingebiel T; Einsele H; Lehrnbecher T
Blood; 2006 Mar; 107(6):2562-9. PubMed ID: 16322466
[TBL] [Abstract][Full Text] [Related]
7. Clinical-scale production of Aspergillus-specific T cells for the treatment of invasive aspergillosis in the immunocompromised host.
Papadopoulou A; Alvanou M; Koukoulias K; Athanasiou E; Lazaridou A; Savvopoulos N; Kaloyannidis P; Markantonatou AM; Vyzantiadis TA; Yiangou M; Anagnostopoulos A; Yannaki E
Bone Marrow Transplant; 2019 Dec; 54(12):1963-1972. PubMed ID: 30867554
[TBL] [Abstract][Full Text] [Related]
8. A novel lentiviral vector-based approach to generate chimeric antigen receptor T cells targeting
Kumaresan PR; Wurster S; Bavisi K; da Silva TA; Hauser P; Kinnitt J; Albert ND; Bharadwaj U; Neelapu S; Kontoyiannis DP
mBio; 2024 Apr; 15(4):e0341323. PubMed ID: 38415653
[TBL] [Abstract][Full Text] [Related]
9. Robust polyfunctional T-helper 1 responses to multiple fungal antigens from a cell population generated using an environmental strain of Aspergillus fumigatus.
Gaundar SS; Clancy L; Blyth E; Meyer W; Gottlieb DJ
Cytotherapy; 2012 Oct; 14(9):1119-30. PubMed ID: 22866666
[TBL] [Abstract][Full Text] [Related]
10. Rapid generation of clinical-grade antiviral T cells: selection of suitable T-cell donors and GMP-compliant manufacturing of antiviral T cells.
Tischer S; Priesner C; Heuft HG; Goudeva L; Mende W; Barthold M; Kloeß S; Arseniev L; Aleksandrova K; Maecker-Kolhoff B; Blasczyk R; Koehl U; Eiz-Vesper B
J Transl Med; 2014 Dec; 12():336. PubMed ID: 25510656
[TBL] [Abstract][Full Text] [Related]
11. Isolation and expansion of human adenovirus-specific CD4+ and CD8+ T cells according to IFN-gamma secretion for adjuvant immunotherapy.
Feuchtinger T; Lang P; Hamprecht K; Schumm M; Greil J; Jahn G; Niethammer D; Einsele H
Exp Hematol; 2004 Mar; 32(3):282-9. PubMed ID: 15003314
[TBL] [Abstract][Full Text] [Related]
12. Adoptive transfer of Aspergillus-specific T cells as a novel anti-fungal therapy for hematopoietic stem cell transplant recipients: Progress and challenges.
Papadopoulou A; Kaloyannidis P; Yannaki E; Cruz CR
Crit Rev Oncol Hematol; 2016 Feb; 98():62-72. PubMed ID: 26527379
[TBL] [Abstract][Full Text] [Related]
13. Generation of cytotoxic T cell responses directed to human leucocyte antigen Class I restricted epitopes from the Aspergillus f16 allergen.
Ramadan G; Davies B; Kurup VP; Keever-Taylor CA
Clin Exp Immunol; 2005 Apr; 140(1):81-91. PubMed ID: 15762878
[TBL] [Abstract][Full Text] [Related]
14. Co-ordinated isolation of CD8(+) and CD4(+) T cells recognizing a broad repertoire of cytomegalovirus pp65 and IE1 epitopes for highly specific adoptive immunotherapy.
Zandvliet ML; van Liempt E; Jedema I; Veltrop-Duits LA; Willemze R; Guchelaar HJ; Falkenburg JH; Meij P
Cytotherapy; 2010 Nov; 12(7):933-44. PubMed ID: 20078388
[TBL] [Abstract][Full Text] [Related]
15. Clinical-scale generation of multi-specific anti-fungal T cells targeting Candida, Aspergillus and mucormycetes.
Tramsen L; Schmidt S; Boenig H; Latgé JP; Lass-Flörl C; Roeger F; Seifried E; Klingebiel T; Lehrnbecher T
Cytotherapy; 2013 Mar; 15(3):344-51. PubMed ID: 23579059
[TBL] [Abstract][Full Text] [Related]
16. Induction of A. fumigatus-specific CD4-positive T cells in patients recovering from invasive aspergillosis.
Jolink H; Hagedoorn RS; Lagendijk EL; Drijfhout JW; van Dissel JT; Falkenburg JH; Heemskerk MH
Haematologica; 2014 Jul; 99(7):1255-63. PubMed ID: 24747947
[TBL] [Abstract][Full Text] [Related]
17. Immune Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation and Association With Occurrence and Outcome of Invasive Aspergillosis.
Stuehler C; Kuenzli E; Jaeger VK; Baettig V; Ferracin F; Rajacic Z; Kaiser D; Bernardini C; Forrer P; Weisser M; Elzi L; Battegay M; Halter J; Passweg J; Khanna N
J Infect Dis; 2015 Sep; 212(6):959-67. PubMed ID: 25748323
[TBL] [Abstract][Full Text] [Related]
18. Short-term in-vitro expansion improves monitoring and allows affordable generation of virus-specific T-cells against several viruses for a broad clinical application.
Geyeregger R; Freimüller C; Stevanovic S; Stemberger J; Mester G; Dmytrus J; Lion T; Rammensee HG; Fischer G; Eiz-Vesper B; Lawitschka A; Matthes S; Fritsch G
PLoS One; 2013; 8(4):e59592. PubMed ID: 23630567
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the T-cell-mediated immune response against the Aspergillus fumigatus proteins Crf1 and catalase 1 in healthy individuals.
Jolink H; Meijssen IC; Hagedoorn RS; Arentshorst M; Drijfhout JW; Mulder A; Claas FH; van Dissel JT; Falkenburg JH; Heemskerk MH
J Infect Dis; 2013 Sep; 208(5):847-56. PubMed ID: 23698813
[TBL] [Abstract][Full Text] [Related]
20. CcpA- and Shm2-Pulsed Myeloid Dendritic Cells Induce T-Cell Activation and Enhance the Neutrophilic Oxidative Burst Response to
Page L; Wallstabe J; Lother J; Bauser M; Kniemeyer O; Strobel L; Voltersen V; Teutschbein J; Hortschansky P; Morton CO; Brakhage AA; Topp M; Einsele H; Wurster S; Loeffler J
Front Immunol; 2021; 12():659752. PubMed ID: 34122417
[No Abstract] [Full Text] [Related]
[Next] [New Search]
